Molecular Mechanisms of Development and Reversal of Alcohol-Induced Liver Fibrosis (R21)

The summary for the Molecular Mechanisms of Development and Reversal of Alcohol-Induced Liver Fibrosis (R21) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Molecular Mechanisms of Development and Reversal of Alcohol-Induced Liver Fibrosis (R21): -Purpose. This Funding Opportunity Announcement (FOA) issued by National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, solicits Research Grant (R21) applications from institutions/organizations that propose to investigate the underlying molecular mechanisms of the development as well as reversal of alcohol-induced liver fibrosis. Liver fibrosis comprises excessive deposition of extracellular matrix (ECM) components, especially collagen, and activation of hepatic stellate cells (HSCs) is the primary event that triggers the process of fibrogenesis. Understanding the mechanisms of alcohol-induced liver fibrosis is important for the development of strategies for prevention and treatment of this condition. This FOA encourages applicants to test small molecules that reverse or prevent alcohol-induced liver fibrosis. -Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R21) award mechanism and runs in parallel with an FOA of identical scientific scope, PA-07-360 that solicits applications under the R01 mechanism. -Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received.
Federal Grant Title: Molecular Mechanisms of Development and Reversal of Alcohol-Induced Liver Fibrosis (R21)
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PA-07-361
Type of Funding: Grant
CFDA Numbers: 93.273
CFDA Descriptions: Alcohol Research Programs
Current Application Deadline: Multiple Receipt Dates - See Link to Full Announce
Original Application Deadline: Multiple Receipt Dates - See Link to Full Announce
Posted Date: Apr 19, 2007
Creation Date: Dec 05, 2008
Archive Date: Apr 16, 2010
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments - Public and State controlled institutions of higher education - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Foreign institutions are eligible to apply.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants
Comprehensive Alcohol Research Centers (P60 Clinical Trial Optional)
Specialized Alcohol Research Centers (P50 Clinical trial Optional)
Mechanisms of Tolerance (R21/R33 - Clinical Trial Required)
Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional)
Behavioral and Integrative Treatment Development Program (R01 Clinical Trial Optional)
Mechanisms of Alcoholic Pancreatitis
Alcohol Abuse and Hiv/Aids in Resource-Poor Societies
Mechanisms of Alcohol-Induced Tissue Injury
More Grants from the National Institutes of Health
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R...
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R...
Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R03 Clinica...
NIDA Program Project Grant Applications (P01 Clinical Trial Optional)
NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2019 FederalGrants.com